Newton, PA-based Bio-Imaging Technologies has purchased a segment of Quintiles Transnational that specializes in providing digital medical imaging services for clinical trials and the healthcare industry. Financial terms were not disclosed. The services
Newton, PA-based Bio-Imaging Technologies has purchased a segment of Quintiles Transnational that specializes in providing digital medical imaging services for clinical trials and the healthcare industry. Financial terms were not disclosed. The services provided by this business unit, called Intelligent Imaging, include image data management, data translation, and digitization for submission of medical image data to the FDA and clinical sponsors, using proprietary interactive software. The unit supports a wide variety of medical information, x-rays, MR, CT, nuclear medicine, PET, and ultrasound scans. Bio-Imaging Technologies specializes in helping clients design and manage the medical imaging component of clinical trials.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.